Radiopharmacies Celebrate the New Year with Long-Awaited FDA ...

JD Supra (press release)-22 hours ago

With regard to compounding, that constitutes “minor deviation” and repackaging, the guidance states that the FDA will not take action for violations of the FD&C ...